Multigate Medical Products UK Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 11937332 (England and Wales)

Unaudited Financial Statements

for the Period 10 April 2019 to 30 April 2020

for

Multigate Medical Products UK Limited

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

B Chaisumdet

REGISTERED OFFICE:

First Floor, St Johns House

16 Church Street

Bromsgrove

Worcestershire

B61 8DN

REGISTERED NUMBER:

11937332 (England and Wales)

ACCOUNTANTS:

Clay Knox Ltd

First Floor, St Johns House

16 Church Street

Bromsgrove

Worcestershire

B61 8DN

FIXED ASSETS

Investments

4

45

CURRENT ASSETS

Debtors

4,500,000

Cash at bank

744

4,500,744

CREDITORS

Amounts falling due within one year

4,502,814

NET CURRENT LIABILITIES

(2,070

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(2,025

)

CAPITAL AND RESERVES

Called up share capital

10

Retained earnings

(2,035

)

SHAREHOLDERS' FUNDS

(2,025

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 April 2020.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2020 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the period ended 30 April 2020 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 16 December 2020 and were signed by:

B Chaisumdet - Director

1.	STATUTORY INFORMATION

Multigate Medical Products UK Limited is a private company, limited by shares , registered in England and

Wales. The company's registered number and registered office address can be found on the Company

Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except

to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the

balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different

from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and

laws that have been enacted or substantively enacted by the period end and that are expected to apply to the

reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that

they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

4.	FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:

Totals

£

COST

Additions

45

At 30 April 2020

45

NET BOOK VALUE

At 30 April 2020

45

5.	RELATED PARTY DISCLOSURES

During the year the company received a loan from its holding company amounting to £4,500,969, this being

the balance at the year end. The loan is not interest bearing nor are there any fixed repayment terms.

During the year the company made a loan to a company in which it holds 45% of the share capital. The loan

amounted to £4,500,000, this being the balance at the year end. The loan is not interest bearing nor are there

any fixed repayment terms.

6.	ULTIMATE CONTROLLING PARTY

The controlling party is Multigate Medical Products Pty Ltd.

Mulitgate Medical Products Pty Ltd is registered in Australia, the registered office address being 27 Llewllyn

Avenue, Villawood, New South Wales, Australia, 2163,